Table 1.
T1D, +TG (n=123) | T1D, −TG (n=129) | p-value | |
---|---|---|---|
Sex (males) | 59 (48%) | 76 (59%) | 0.082 |
Age (y) | 13.5 ± 3.7 | 13.9 ± 2.8 | 0.37 |
Duration of Diabetes (y) | 7.0 ± 4.4 | 6.0 ± 4.3 | 0.078 |
Height z-score | 0.14 ± 1.28 | 0.24 ± 0.93 | 0.48 |
Weight z-score | 0.29 ± 0.98 | 0.43 ± 0.94 | 0.24 |
BMI z-score | 0.07 ± 2.28 | 0.36 ± 1.04 | 0.20 |
Vitamin D 25OH (ng/mL) | 34 ± 9 | 33 ± 8 | 0.38 |
Ferritin (ng/mL) | 37 (32–42) | 40 (36–45) | 0.25 |
Urine N-Telopeptides (nmol BCE/mmol creat) | 223 (188–265) | 239 (205–278) | 0.55 |
TSH | 2.1 (1.8–2.4) | 2.0 (1.8–2.4) | 0.78 |
HbA1c (%) | 8.3 (8.1–8.6) | 8.6 (8.3–8.9) | 0.19 |
BMD L1-L4 z-score | −0.45 ± 1.22 | 0.09 ± 1.10 | 0.0003 |
Low BMD¶ | 15 (12%) | 4 (3%) | 0.0076* |
Symptoms | 57 (46%) | 46 (36%) | 0.085 |
Data are presented as mean ± SD, geometric mean and 95% CI or frequency (%).
Fisher Exact P-value due to cell sizes < 5
Low BMD defined by BMD L1-L4 z-score (for age and gender) of ≤ −2 SD.